Cargando…

Different Features of Interleukin-37 and Interleukin-18 as Disease Activity Markers of Adult-Onset Still’s Disease

The aim of this study was to evaluate the usefulness of serum interleukin (IL)-37 and IL-18 as disease activity markers of adult-onset Still’s disease (AOSD) and to compare their related clinical features. Forty-five patients with a set of high and subsequent low disease activity status of AOSD were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nam, Seoung Wan, Kang, SuMan, Lee, Jun Hyeok, Yoo, Dae Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956170/ https://www.ncbi.nlm.nih.gov/pubmed/33652679 http://dx.doi.org/10.3390/jcm10050910

Ejemplares similares

Interleukin-37 is increased in adult-onset Still’s disease and associated with disease activity
por: Chi, Huihui, et al.
Publicado: (2018)

The Role of Interleukin 18/Interleukin 18-Binding Protein in Adult-Onset Still’s Disease and Systemic Juvenile Idiopathic Arthritis
por: Girard-Guyonvarc’h, Charlotte, et al.
Publicado: (2022)

Anti-Interleukin-1 Agents in Adult Onset Still's Disease
por: Giampietro, Cecilia, et al.
Publicado: (2012)

Interleukin-18 as a diagnostic marker of adult-onset Still’s disease in older patients: a case report and review of the literature
por: Usuda, Daisuke, et al.
Publicado: (2018)

The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis
por: Omenesa Bello, Ramatu, et al.
Publicado: (2018)

Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19
por: Chen, Po-Ku, et al.
Publicado: (2021)

The emerging role of interleukin‐37 in cardiovascular diseases
por: Zhuang, Xinyu, et al.
Publicado: (2017)

The Role of Interleukin-37 in the Pathogenesis of Allergic Diseases
por: Shilovskiy, I. P., et al.
Publicado: (2019)

Utility and drawbacks of [18]F-fluorodeoxyglucose positron emission tomography in the evaluation of adult-onset Still’s disease
por: Yoo, Dae Hyun
Publicado: (2017)

Reviews of Interleukin-37: Functions, Receptors, and Roles in Diseases
por: Jia, Hailin, et al.
Publicado: (2018)

Roles of interleukins (interleukin-18 and interleukin-17a) and transforming growth factor-beta markers in the pathogenesis of diabetic kidney diseases
por: Mezher, Maysam Adnan, et al.
Publicado: (2023)

Interleukin-18 in Health and Disease
por: Yasuda, Koubun, et al.
Publicado: (2019)

Two cases of multiple-drug-resistant adult-onset Still's disease treated successfully with tocilizumab - the relationship between interleukin 6 and 18
por: Sato, Kojiro, et al.
Publicado: (2012)

Biology of interleukin-37 and its role in autoimmune diseases (Review)
por: Zeng, Huiqiong, et al.
Publicado: (2022)

Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still’s disease from sepsis
por: Koga, Tomohiro, et al.
Publicado: (2020)

Interleukin-18 in Inflammatory Kidney Disease
por: Hirooka, Yasuaki, et al.
Publicado: (2021)

Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
por: Chen, Bingni, et al.
Publicado: (2015)

IL-18 Serum Level in Adult Onset Still's Disease: A Marker of Disease Activity
por: Colafrancesco, Serena, et al.
Publicado: (2012)

Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety
por: Hong, Dongsheng, et al.
Publicado: (2014)

Interleukin-17 and interleukin-18 levels in different stages of inflammatory periodontal disease
por: Chitrapriya, Muthugounder Nalanaswamy, et al.
Publicado: (2015)

Interleukin-37 as fundamental inhibitor of innate immunity
por: Bufler, P
Publicado: (2011)

Modulation of Liver Inflammation and Fibrosis by Interleukin-37
por: Mountford, Steffeni, et al.
Publicado: (2021)

Interleukin-37 is involved in the immunopathogenesis of infectious mononucleosis
por: Zhao, Mingsheng, et al.
Publicado: (2023)

Interleukin‐37 and Dendritic Cells Treated With Interleukin‐37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction
por: Zhu, Ruirui, et al.
Publicado: (2016)

Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still’s disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity
por: Kudela, Holger, et al.
Publicado: (2019)

Elevated levels of interleukin‐35 and interleukin‐37 in adult patients with obstructive sleep apnea
por: Chen, Bi, et al.
Publicado: (2021)

Polymorphism Analysis of Interleukin-18 and Interleukin-37 Genes in Hepatitis B Infections with Different Outcomes: A Preliminary Report from an Iranian Population
por: Molaei, Vahid, et al.
Publicado: (2023)

Interleukin-18 and IL-18BP in inflammatory dermatological diseases
por: Wang, Xiaoyun, et al.
Publicado: (2023)

Interleukin-18 Binding Protein in Immune Regulation and Autoimmune Diseases
por: Park, Seung Yong, et al.
Publicado: (2022)

Atypical cutaneous features in a patient with adult-onset Still’s disease
por: Jeong, Woo Seong, et al.
Publicado: (2021)

Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still’s Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults
por: Shiga, Toshihiko, et al.
Publicado: (2021)

Interleukin 37 is a fundamental inhibitor of innate immunity
por: Nold, Marcel F, et al.
Publicado: (2010)

The potential of interleukin-37 as an effective therapeutic agent in asthma
por: Zhang, Lina, et al.
Publicado: (2017)

Interleukin 18 in the CNS
por: Alboni, Silvia, et al.
Publicado: (2010)

Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients
por: Ahmed, Aeshah A., et al.
Publicado: (2022)

Evaluation of interleukins 37 and 38 and vitamin D status in the serum of women with Graves' disease
por: Ibrahim, Hiba Y., et al.
Publicado: (2022)

18. A case of atypical adult-onset Still’s disease
por: McKnight, Jonathan, et al.
Publicado: (2019)

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study
por: Colafrancesco, Serena, et al.
Publicado: (2017)

Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts
por: Colafrancesco, Serena, et al.
Publicado: (2019)

Interleukin 18 as an early marker or prognostic factor in acute pancreatitis
por: Janiak, Adam, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fajq3m0d1rocmpihtr3o2uoi4f